Why Bank of America Could Be the Best Value Among the Big Banks Right Now

Bank of America is down about 7% year to date but is highlighted as inexpensive at 11x forward earnings and a 0.92 PEG ratio. Deposits rose 3% in Q1 for the 11th straight quarter, while net interest income increased 9% year over year and 2026 NII guidance was raised to 6%-8% growth. Wall Street analysts are constructive, with 85% rating the stock a buy and a median 12-month price target of $61.50, implying 22% upside.

Analysis

BAC’s setup is less about being “cheap” and more about being a high-beta beneficiary of a benign macro regime that the market is still underweighting. The second-order winner is not just BAC’s NII line; it is the entire fee and operating leverage stack that improves when deposit stability reduces funding volatility and management can keep reinvesting in share repurchases. If the deposit franchise remains sticky, BAC’s implied cost of funds should stay below peers that rely more heavily on wholesale or price-sensitive balances, which matters more in a world where loan growth is only modestly accelerating.

The key risk is that the market is treating this as a valuation mean-reversion story when it is really a duration-sensitive earnings story. A shallow Fed easing cycle or stable policy rates is constructive; a faster-cut scenario can actually compress NII faster than loan demand re-accelerates, while a late-cycle credit wobble would hit the stock before consensus has time to revise estimates. In other words, the next 1-2 quarters are probably driven by rate expectations, but the 6-12 month outcome hinges on whether credit remains “contained enough” for buybacks and multiple expansion to do the heavy lifting.

The contrarian miss is that BAC may deserve a lower multiple than JPM structurally, but not necessarily this large a discount if operating leverage and capital returns stay intact. The bigger opportunity may be in trading the spread between the two rather than making an outright macro call: if the economy avoids a hard landing, BAC can rerate faster from a depressed base, while JPM’s premium multiple has less room to expand. The upside is likely more in sentiment normalization than in an earnings surprise, which means positioning matters: this can work even without a blockbuster fundamental inflection if investor flows rotate back into large-cap financials.

Key Decisions for Investors

• Long BAC / short JPM in a 3-6 month pair trade: express mean-reversion in valuation spread while keeping sector beta neutral; target 10-15% relative outperformance if credit stays stable and rates remain range-bound.
• Buy BAC on pullbacks over the next 2-4 weeks, ideally into any rate-driven weakness; risk/reward favors entry if the stock is 8-10x forward earnings implied on a broader market de-risking.
• Sell out-of-the-money BAC puts 1-2 quarters out to monetize elevated uncertainty and get paid to own the stock below current levels; attractive if you want long exposure with lower basis.
• Add JPM as a hedge against a benign macro outcome only if you need bank exposure with less earnings volatility; otherwise BAC offers better upside torque per dollar of capital.
• If BAC re-rates to 12.5-13x forward earnings before the next earnings cycle, trim 25-50% of the position; the market is likely to cap valuation unless management upgrades guidance again.